162 related articles for article (PubMed ID: 28422118)
21. GPR40 protein levels are crucial to the regulation of stimulated hormone secretion in pancreatic islets. Lessons from spontaneous obesity-prone and non-obese type 2 diabetes in rats.
Meidute Abaraviciene S; Muhammed SJ; Amisten S; Lundquist I; Salehi A
Mol Cell Endocrinol; 2013 Dec; 381(1-2):150-9. PubMed ID: 23911664
[TBL] [Abstract][Full Text] [Related]
22. Hyperglycemia-induced B cell toxicity. The fate of pancreatic islets transplanted into diabetic mice is dependent on their genetic background.
Korsgren O; Jansson L; Sandler S; Andersson A
J Clin Invest; 1990 Dec; 86(6):2161-8. PubMed ID: 2254465
[TBL] [Abstract][Full Text] [Related]
23. Protection of pancreatic beta-cells: is it feasible?
Bonora E
Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
[TBL] [Abstract][Full Text] [Related]
24. Pathophysiology of type 2 diabetes: targeting islet cell dysfunction.
Spellman CW
J Am Osteopath Assoc; 2010 Mar; 110(3 Suppl 2):S2-7. PubMed ID: 20382838
[TBL] [Abstract][Full Text] [Related]
25. Impaired glucose-stimulated insulin secretion is coupled with exocrine pancreatic lesions in the Cohen diabetic rat.
Weksler-Zangen S; Raz I; Lenzen S; Jörns A; Ehrenfeld S; Amir G; Oprescu A; Yagil Y; Yagil C; Zangen DH; Kaiser N
Diabetes; 2008 Feb; 57(2):279-87. PubMed ID: 17977959
[TBL] [Abstract][Full Text] [Related]
26. Exogenous glucocorticoids and a high-fat diet cause severe hyperglycemia and hyperinsulinemia and limit islet glucose responsiveness in young male Sprague-Dawley rats.
Beaudry JL; D'souza AM; Teich T; Tsushima R; Riddell MC
Endocrinology; 2013 Sep; 154(9):3197-208. PubMed ID: 23766132
[TBL] [Abstract][Full Text] [Related]
27. [Why is insulin release from beta cells insufficient in type 2 diabetes?].
Grill V
Tidsskr Nor Laegeforen; 2000 Sep; 120(23):2796-8. PubMed ID: 11107928
[TBL] [Abstract][Full Text] [Related]
28. Insulin resistance causes increased beta-cell mass but defective glucose-stimulated insulin secretion in a murine model of type 2 diabetes.
Asghar Z; Yau D; Chan F; Leroith D; Chan CB; Wheeler MB
Diabetologia; 2006 Jan; 49(1):90-9. PubMed ID: 16362284
[TBL] [Abstract][Full Text] [Related]
29. Beta-cell mass depletion precedes the onset of hyperglycaemia in the GK rat, a genetic model of non-insulin-dependent diabetes mellitus.
Movassat J; Saulnier C; Portha B
Diabete Metab; 1995 Dec; 21(5):365-70. PubMed ID: 8586154
[TBL] [Abstract][Full Text] [Related]
30. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N
Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624
[TBL] [Abstract][Full Text] [Related]
31. [Anatomical and functional plasticity of pancreatic beta-cells and type 2 diabetes].
Cerasi E; Ktorza A
Med Sci (Paris); 2007 Oct; 23(10):885-94. PubMed ID: 17937902
[TBL] [Abstract][Full Text] [Related]
32. Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes.
Matveyenko AV; Butler PC
Diabetes; 2006 Jul; 55(7):2106-14. PubMed ID: 16804082
[TBL] [Abstract][Full Text] [Related]
33. [Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus].
Liu J; Li YB; Shao H; Li YX; Yuan YH; Xiao YB; Weng JP
Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1252-5. PubMed ID: 17686259
[TBL] [Abstract][Full Text] [Related]
34. The Potential Protective Action of Vitamin D in Hepatic Insulin Resistance and Pancreatic Islet Dysfunction in Type 2 Diabetes Mellitus.
Leung PS
Nutrients; 2016 Mar; 8(3):147. PubMed ID: 26959059
[TBL] [Abstract][Full Text] [Related]
35. Emerging concepts in the pathophysiology of type 2 diabetes mellitus.
Surampudi PN; John-Kalarickal J; Fonseca VA
Mt Sinai J Med; 2009 Jun; 76(3):216-26. PubMed ID: 19421965
[TBL] [Abstract][Full Text] [Related]
36. Glucocorticoid treatment and endocrine pancreas function: implications for glucose homeostasis, insulin resistance and diabetes.
Rafacho A; Ortsäter H; Nadal A; Quesada I
J Endocrinol; 2014 Dec; 223(3):R49-62. PubMed ID: 25271217
[TBL] [Abstract][Full Text] [Related]
37. [Amylin/IAPP (islet amyloid polypeptide)--physiology and clinical significance].
Ludvik B
Wien Klin Wochenschr; 1997 Jun; 109(11):379-83. PubMed ID: 9281227
[TBL] [Abstract][Full Text] [Related]
38. Functional and metabolic perturbations in isolated pancreatic islets from the GK rat, a genetic model of noninsulin-dependent diabetes.
Giroix MH; Vesco L; Portha B
Endocrinology; 1993 Feb; 132(2):815-22. PubMed ID: 8425496
[TBL] [Abstract][Full Text] [Related]
39. Induction of beta-cell rest by a Kir6.2/SUR1-selective K(ATP)-channel opener preserves beta-cell insulin stores and insulin secretion in human islets cultured at high (11 mM) glucose.
Ritzel RA; Hansen JB; Veldhuis JD; Butler PC
J Clin Endocrinol Metab; 2004 Feb; 89(2):795-805. PubMed ID: 14764798
[TBL] [Abstract][Full Text] [Related]
40. The HND mouse, a nonobese model of type 2 diabetes mellitus with impaired insulin secretion.
Horio F; Teradaira S; Imamura T; Anunciado RV; Kobayashi M; Namikawa T; Niki I
Eur J Endocrinol; 2005 Dec; 153(6):971-9. PubMed ID: 16322404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
